Breast cancer in association with thyroid disorders

Basit Öğe Kaydı
dc.authorid0000-0002-4075-6692en_US
dc.contributor.authorNarin, Y.
dc.contributor.authorDemirbaş, S.
dc.contributor.authorÖnde, M.E.
dc.contributor.authorSayan, Ö.
dc.contributor.authorKandemir, E.G.
dc.contributor.authorYaylacı, M.
dc.contributor.authorÖztürk, A.
dc.date.accessioned2024-07-12T21:02:57Z
dc.date.available2024-07-12T21:02:57Z
dc.date.issued2003en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractBreast cancer is a hormone-dependent neoplasm. Conflicting results regarding the clinical correlation between breast cancer and thyroid diseases have been reported in the literature. Many studies showed that thyroid diseases are common among women with breast cancer [1–6], whereas other reports did not confirm such an association of breast cancer with thyroid diseases [7–11]. Almost every form of thyroid disease, including nodular hyperplasia [12], hyperthyroidism [13] and thyroid cancer [14, 15], has been identified in association with breast cancer. These findings have led to the investigation of the relationship between breast cancer and autoimmune thyroid diseases (AITDs). Such a relationship is not a new observation, and some authors have reported a higher prevalance of AITDs among breast cancer patients than in age-matched control individuals [16–18]. The precise significance of this association remains elusive, and some reports have shown that the presence of thyroid peroxidase (TPO) antibodies is associated with a significant improvement in outcome among breast cancer patients [19] and is of similar importance to other prognostic indices such as axillary nodal status and tumour size [20]. The aim of the present prospective study was to determine the prevalence of thyroid diseases in patients with breast cancer as compared with that in the general female population.en_US
dc.identifier.citationTürken, O., Narin, Y., Demirbaş, S., Önde, M.E., Sayan, Ö., Kandemir, E.G., Yaylacı, M. ve Öztürk, A. (2003). Breast cancer in association with thyroid disorders. Breast Cancer Research, Biomedcentral. 5(5), s. R110-R113.en_US
dc.identifier.endpageR113en_US
dc.identifier.issn1465-542X
dc.identifier.issue5en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageR110en_US
dc.identifier.urihttps://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr609#citeas
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3595
dc.identifier.volume5en_US
dc.institutionauthorTürken, Orhan
dc.language.isoenen_US
dc.publisherBiomedcentralen_US
dc.relation.ispartofBreast Cancer Researchen_US
dc.relation.isversionof10.1186/bcr609en_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsCC0 1.0 Universal*
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.snmzKY00452
dc.subjectbreasten_US
dc.subjectcanceren_US
dc.subjectthyroiden_US
dc.titleBreast cancer in association with thyroid disordersen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu